No. of Recommendations: 0
Have to agree this has been a really tough spell for MDP. I was very close to bailing, but I re-upped to get other stock ideas which I blend with Options/Pro. Plus I had ridden MDP through the 2008 boom & bust and it worked out in the end. This cycle has been less forgiving.

China Green Agriculture? The thesis might pan out, but sketchy accounting is a dealbraker. Ugh.
YONG, even with better accounting, has been a dog as well.

ZIP? It's been on a downward trend since the IPO. High risk, speculative valuation. Time will tell, but if we keep digging a hole, the payoff gets further out.

EXEL? This one's going binary. I'm glad I doubled-down recently for a one-day pop, but if it doesn't pan out, this will be a writeoff. I'm hoping someone knows something I don't know, because FDA approvals are notoriously unpredictable.

ARO? I originally bought in, but did my own review and bailed in July.

CSE? It's on a better trajectory, but a long-term challenged position.

Returns in my MDP portfolio were saved by IPGP, BOOM, UNH, and my personal, off-rec decisions (e.g., LULU, a retail 3-banger I chose instead of ARO). I've given up sticking to the recs in MDP - I look at them as food for thought.
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.